Results 41 to 50 of about 225,011 (214)

Types and Structure of Complications, and Causes of Mortality with Different Combinations of Immunosuppressants in Patients of Undergoing Organ Transplantation

open access: yesHeart Vessels and Transplantation, 2017
We aimed to retrospectively analyze morbidity and mortality in recipients of kidney and liver transplant receiving immunosuppressive therapy (tacrolimus and cyclosporine with mycophenolate mofetil and mycophenolic acid).
Jamalbek I. Ashimov   +1 more
doaj   +1 more source

A two-centre study investigating the association between brain natriuretic peptides & outcomes in continuous flow left ventricular assist device recipients

open access: yesJournal of Cardiothoracic Surgery
Background Natriuretic peptides are useful prognostic markers in patients with heart failure and this study aims to evaluate the association between N-terminal pro-brain natriuretic peptide and outcomes in patients with a continuous-flow left ventricular
Maria Lambadaris   +7 more
doaj   +1 more source

Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

open access: yesHaematologica, 2013
Delayed immune recovery is a characteristic feature of allogeneic hematopoietic stem cell transplantation in adult recipients. Although recipient thymic T-cell neogenesis contributes to T-cell regeneration after transplantation, thymic recovery in the ...
Zachariah McIver   +8 more
doaj   +1 more source

Left ventricular assist device implantation as bridge to heart transplantation [PDF]

open access: yesScripta Medica, 2017
Heart transplantation is a method of choice for the surgical treatment of a terminal stage of cardiac insufficiency. The lack of donors that all health systems in the world are experiencing has led to the intensive development of devices for permanent ...
Terzić Duško   +4 more
doaj  

Clinical Transplantation of the Heart

open access: yesAnnals of Surgery, 1972
CARDIAC DISEASE represents the leading cause of death in the United States.14 Many surgical procedures have been introduced which incrementally have been demonstrated to be therapeutic: closed and open repair of congenital heart disease, rheumatic and arteriosclerotic valvular replacement, and the current experience with myocardial revascularization ...
Randall B. Griepp   +3 more
openaire   +4 more sources

Extracellular vesicles from dental pulp mesenchymal stem cells modulate macrophage phenotype during acute and chronic cardiac inflammation in athymic nude rats with myocardial infarction

open access: yesInflammation and Regeneration
Background/aims Extracellular vesicles (EVs) derived from dental pulp mesenchymal stem cells (DP-MSCs) are a promising therapeutic option for the treatment of myocardial ischemia.
Elena Amaro-Prellezo   +10 more
doaj   +1 more source

Transplantation of the heart and both lungs: II. Experimental cardiopulmonary transplantation [PDF]

open access: bronze, 1969
D B Longmore   +4 more
openalex   +1 more source

The Future of Heart Transplantation [PDF]

open access: yesAmerican Journal of Transplantation, 2012
The field of heart transplantation has seen significant progress in the past 40 years. However, the breakthroughs in long-term outcome have seen stagnation in the past decade. Through advances in genomics and transcriptomics, there is hope that an era of personalized transplant therapy lies in the future.
openaire   +2 more sources

Home - About - Disclaimer - Privacy